Decoy Therapeutics (DCOY) Inventory Average (2016 - 2019)
Decoy Therapeutics (DCOY) posted quarterly Inventory Average of $147758.5 for Q2 2019, down 57.41% year-over-year from $346944.5 in Q2 2018, and down 15.93% quarter-over-quarter from $175758.5 in Q1 2019.
Decoy Therapeutics (DCOY) Inventory Average (2016 - 2019) Analysis & Trends
Decoy Therapeutics (DCOY) has reported Inventory Average for 4 consecutive years, with $147758.5 the latest figure, recorded in Q2 2019.
- In Q2 2019, Inventory Average fell 57.41% year-over-year to $147758.5; the TTM figure through Jun 2019 stood at $147758.5 (down 57.41% YoY), while the FY2018 annual figure was $309405.5, down 30.16% from the prior year.
- Inventory Average declined to $147758.5 in Q2 2019 per DCOY's latest filing, from $175758.5 in the prior quarter.
- Across five years, Inventory Average topped out at $611090.5 in Q3 2017 and bottomed at $147758.5 in Q2 2019.
- Historically, Inventory Average has averaged $339867.3 across 4 years, with a median of $342455.0 in 2016.
- Annual changes were most pronounced in 2017 — Inventory Average surged 184.98% — and 2018, when it tumbled 59.15%.
- Decoy Therapeutics' Inventory Average stood at $342455.0 in 2016, then soared by 41.02% to $482943.5 in 2017, then plunged by 57.51% to $205219.5 in 2018, then fell by 28.0% to $147758.5 in 2019.
- Business Quant data shows DCOY's Inventory Average at $147758.5 in Q2 2019, $175758.5 in Q1 2019, and $205219.5 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 90.57 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 196.36 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 137.65 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Decoy Therapeutics | 1.75 Mn | 1.75 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 147,758.50 |
| Mar 31, 2019 | 175,758.50 |
| Dec 31, 2018 | 205,219.50 |
| Sep 30, 2018 | 249,606.00 |
| Jun 30, 2018 | 346,944.50 |
| Mar 31, 2018 | 425,043.50 |
| Dec 31, 2017 | 482,943.50 |
| Sep 30, 2017 | 611,090.50 |
| Jun 30, 2017 | 551,253.50 |
| Mar 31, 2017 | 434,227.00 |
| Dec 31, 2016 | 342,455.00 |
| Sep 30, 2016 | 252,540.00 |
| Jun 30, 2016 | 193,435.50 |